Sustained Virologic Response in Chronic Hcv Infection with 4 Weeks of Anti-viral Therapy

被引：0
|
作者：
Dorey-Stein, Zachariah [1 ]
Kutmah, Ahmad [1 ]
Alsabbagh, Mohammed Eyad Yaseen [1 ]
机构：
[1] Temple Univ, Philadelphia, PA 19122 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2016年 / 111卷
关键词：
D O I：
10.14309/00000434-201610001-02027
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2027
引用
收藏
页码：S966 / S966
页数：1
相关论文
共 50 条
  • [31] Chronic hepatitis C - Genotypes and response to anti-viral therapy among Saudi patients
    Al-Traif, I
    Handoo, FA
    Al-Jumah, A
    Al-Nasser, M
    SAUDI MEDICAL JOURNAL, 2004, 25 (12) : 1935 - 1938
  • [32] SUSTAINED VIROLOGIC RESPONSE IN THE ANTIVIRAL TREATMENT OF HCV-INFECTION AFTER LIVER TRANSPLANTATION
    Yaroshenko, Ekaterina
    Kornilov, Maxim
    Moysyuk, Yan
    TRANSPLANT INTERNATIONAL, 2013, 26 : 291 - 291
  • [33] Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy
    Toyoda, Hidenori
    Yasuda, Satoshi
    Moriya, Akio
    Itobayashi, Ei
    Uojima, Haruki
    Watanabe, Tsunamasa
    Atsukawa, Masanori
    Arai, Taeang
    Ishikawa, Toru
    Mikami, Shigeru
    Hiraoka, Atsushi
    Tsuji, Kunihiko
    Oikawa, Tsunekazu
    Tsubota, Akihito
    Nozaki, Akito
    Chuma, Makoto
    Abe, Hiroshi
    Shima, Toshihide
    Kumada, Takashi
    Tanaka, Junko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1231 - 1234
  • [34] ANTI-VIRAL THERAPY TODAY
    TOVO, PA
    MINERVA MEDICA, 1980, 71 (49) : 3633 - 3637
  • [35] ANTI-VIRAL THERAPY IN HAEMODIALYZED HCV PATIENTS: EFFICACY, TOLERANCE AND TREATMENT STRATEGY
    Deltenre, P.
    Thabut, D.
    Tran, A.
    Moreno, C.
    Castel, H.
    El Nady, M.
    Canva, V.
    Louvet, A.
    Ben Ali, H.
    Provot, F.
    Glowacki, F.
    Dharancy, S.
    Stanke, F.
    Henrion, J.
    Noel, C.
    Mathurin, P.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S223 - S223
  • [36] ANTI-VIRAL THERAPY IN HAEMODIALYZED HCV PATIENTS: EFFICACY, TOLERANCE AND TREATMENT STRATEGY
    Deltenre, Pierre
    Thabut, Dominique
    Tran, Albert
    Castel, Helene
    El Nady, Mohamed
    Canva, Valerie
    Louvet, Alexandre
    Ben Ali, Houssem
    Provot, Francois
    Glowacki, Francois
    Dharancy, Sebastien
    Stanke, Francoise
    Henrion, Jean
    Noel, Christian
    Mathurin, Philippe
    HEPATOLOGY, 2008, 48 (04) : 851A - 852A
  • [37] Sofosbuvir Combination Therapy and Chronic Hepatitis C Infection: Is Cultural Background a Predictor of Sustained Virologic Response?
    Tierney, Amber
    Lake, John R.
    Mahgoub, Amar
    Schmitt, Carolyn
    Wang, Qi
    Hassan, Mohamed A.
    HEPATOLOGY, 2015, 62 : 795A - 795A
  • [38] Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy
    Deltenre, P.
    Moreno, C.
    Tran, A.
    Ollivier, I.
    Provot, F.
    Stanke, F.
    Lazrek, M.
    Castel, H.
    Canva, V.
    Louvet, A.
    Colin, M.
    Glowacki, F.
    Dharancy, S.
    Henrion, J.
    Hazzan, M.
    Noel, C.
    Mathurin, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) : 454 - 461
  • [39] ADVANCES IN ANTI-VIRAL THERAPY
    EGGERS, HJ
    MEDIZINISCHE KLINIK, 1978, 73 (27) : 1017 - 1018
  • [40] Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure
    Foster, Graham R.
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric J.
    Diago, Moises
    Roberts, Stuart
    Pockros, Paul J.
    Younossi, Zobair
    Lonjon-Domanec, Isabelle
    De Meyer, Sandra
    Luo, Don
    George, Shelley
    Beumont, Maria
    Picchio, Gaston
    JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 488 - 494
12345